PEG-rhG-CSF in Secondary Prevention of Nab-Paclitaxel Combined With S-1 in Advanced Pancreatic Cancer
NCT04518800
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
PEG-rhG-CSF
Pancreatic Cancer
Interventions
DRUG:
Jin Youli(PEG-rhG-CSF)
Sponsor
Chinese PLA General Hospital